Chemoinformaics analysis of Ethyl octadec-9-enoate
| Molecular Weight | 310.522 | nRot | 16 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 2 |
| Exact Molecular Weight | 310.287 | nRing | 0 |
| Solubility: LogS | -6.66 | nHRing | 0 |
| Solubility: LogP | 7.489 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 60.3421 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.183 |
| Synth | 2.071 |
| Natural Product Likeliness | 0.586 |
| NR-PPAR-gamma | 0.11 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.784 |
| MDCK | 0.0000246 |
| BBB | 0.097 |
| PPB | 0.994108 |
| VDSS | 3.673 |
| FU | 0.00968525 |
| CYP1A2-inh | 0.534 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.47 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.297 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.532 |
| CYP2d6-sub | 0.082 |
| CYP3a4-inh | 0.47 |
| CYP3a4-sub | 0.063 |
| CL | 3.231 |
| T12 | 0.41 |
| hERG | 0.22 |
| Ames | 0.002 |
| ROA | 0.016 |
| SkinSen | 0.962 |
| Carcinogencity | 0.046 |
| EI | 0.947 |
| Respiratory | 0.824 |
| NR-Aromatase | 0.101 |
| Antiviral | No |
| Prediction | 0.526842 |